Next Article in Journal
Advances of Cobalt Nanomaterials as Anti-Infection Agents, Drug Carriers, and Immunomodulators for Potential Infectious Disease Treatment
Next Article in Special Issue
Early Negativization of SARS-CoV-2 Infection by Nasal Spray of Seawater plus Additives: The RENAISSANCE Open-Label Controlled Clinical Trial
Previous Article in Journal
Evaluation of a Proposed Approach for the Determination of the Bioequivalence Acceptance Range for Narrow Therapeutic Index Drugs in the European Union
Previous Article in Special Issue
Development of Nasal Vaccines and the Associated Challenges
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(11), 2350; https://doi.org/10.3390/pharmaceutics14112350
Action Date Notes Link
article xml file uploaded 31 October 2022 09:57 CET Original file -
article xml uploaded. 31 October 2022 09:57 CET Update https://www.mdpi.com/1999-4923/14/11/2350/xml
article pdf uploaded. 31 October 2022 09:57 CET Version of Record https://www.mdpi.com/1999-4923/14/11/2350/pdf
article html file updated 31 October 2022 09:58 CET Original file -
article html file updated 5 November 2022 10:34 CET Update -
article html file updated 28 February 2023 20:46 CET Update -
article html file updated 2 March 2023 01:47 CET Update https://www.mdpi.com/1999-4923/14/11/2350/html
Back to TopTop